The Pep are moving their main stock market listing to the US, to...

The Pep are moving their main stock market listing to the US, to tap into a bigger biotech investment market. I believe (check throught the anns and media reports) they are seeking to raise approx US$75 million, and they will list on the NASDAQ. The shares will still trade on the ASX, but they will be CHESS depositary interests (CDIs). If you are a holder you would have received a letter, so you could elect to receive CDIs or US stock. The new ASX ticker is PLI/PLIO, and I think they start trading on the 22nd Oct.

cheers,
toadmussen.